Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line
Myxofibrosarcoma (MFS) belongs to the group of sarcoma tumors, which represent only 1% of the totality of adult tumors worldwide. Thus, given the rare nature of this cancer, this makes the availability of MFS cell lines difficult. In an attempt to partially fill this gap, we immortalized a primary c...
Main Authors: | Giacomo Miserocchi, Alessandro De Vita, Laura Mercatali, Federica Recine, Chiara Liverani, Chiara Spadazzi, Federica Pieri, Nada Riva, Alberto Bongiovanni, Roberto Casadei, Valentina Fausti, Toni Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/7/11/186 |
Similar Items
-
Myxofibrosarcoma primary cultures: molecular and pharmacological profile
by: Alessandro De Vita, et al.
Published: (2017-12-01) -
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need
by: Silvia Vanni, et al.
Published: (2023-04-01) -
Low-grade Myxofibrosarcoma in the Mandible: A Rare Case Report
by: Neda Kargahi, et al.
Published: (2017-04-01) -
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives
by: Silvia Vanni, et al.
Published: (2022-06-01) -
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
by: Enrico Lucarelli, et al.
Published: (2023-10-01)